A federal appeals court denies ex-Spectranetics CEO John Schulte's bid to overturn his conviction on a single count of lying to the FBI and declines to revisit the case.
Former Spectranetics (NSDQ:SPNC) CEO John Schulte's 2012 conviction on a single count of lying to federal investigators survived his appeal to an appeals court, meaning his sentence of a year's probation will stand.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kylz6X
Cap comentari:
Publica un comentari a l'entrada